Specifically, TCL6 was positively correlated with tumor infiltration with immune cells, including CD8+ and CD4+ T lymphocytes, neutrophils, B and DCs, as well as with the expression of PD-1, PD-L1, PD-L2 and CTLA-4 immune checkpoint molecules [119]. Here, CTLA4 is linked to neoplasm.